MedPath

University Of California, San Francisco

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

Phase 2
Conditions
Kidney Cancer
First Posted Date
2003-01-27
Last Posted Date
2014-01-06
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00030888
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSF Comprehensive Cancer Center, San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Phase 2
Completed
Conditions
Non-melanomatous Skin Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-06-26
Lead Sponsor
University of California, San Francisco
Target Recruit Count
60
Registration Number
NCT00023621
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSF Comprehensive Cancer Center, San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York, United States

Herbal Therapy in Treating Women With Metastatic Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-09-17
Lead Sponsor
University of California, San Francisco
Target Recruit Count
21
Registration Number
NCT00028977
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSF Comprehensive Cancer Center, San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cancer Research Network, Incorporated, Plantation, Florida, United States

Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Drug/Agent Toxicity by Tissue/Organ
First Posted Date
2003-01-27
Last Posted Date
2011-02-23
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00028964
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSF Comprehensive Cancer Center, San Francisco, California, United States

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

Phase 1
Completed
Conditions
Sarcoma, Kaposi
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00002262
Locations
๐Ÿ‡บ๐Ÿ‡ธ

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, United States

Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00002031
Locations
๐Ÿ‡บ๐Ÿ‡ธ

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, United States

A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease

Not Applicable
Completed
Conditions
Mycobacterium Avium-intracellulare Infection
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00002058
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Keith Med Group, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco Gen Hosp, San Francisco, California, United States

Diuretics, Hypertension, and Arrhythmias Clinical Trial

Phase 3
Completed
Conditions
Cardiovascular Diseases
Death, Sudden, Cardiac
Heart Arrest
Heart Diseases
Hypertension
First Posted Date
1999-10-28
Last Posted Date
2013-09-19
Lead Sponsor
University of California, San Francisco
Target Recruit Count
233
Registration Number
NCT00000525

Inhaled NO in Prevention of Chronic Lung Disease

Phase 3
Completed
Conditions
Bronchopulmonary Dysplasia
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2015-03-05
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00000548
ยฉ Copyright 2025. All Rights Reserved by MedPath